Somatropin (rDNA origin, Pfizer)

生长激素（辉瑞）

Report date: 2026/05/12 20:00:17

Base Information

Drug NameSomatropin (rDNA origin, Pfizer)
Drug Alias NameRecombinant somatropin (rDNA origin, Pfizer)生长激素类（辉瑞）Recombinant human growth hormone (rDNA origin, Pfizer)重组人生长激素（辉瑞）Somatropinum (rDNA origin, Pfizer) +[12] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiencyCoronavirus Disease 2019 (COVID-19)Idiopathic short stature +[19] 
Global Approved IndicationsGrowth hormone deficiencyIdiopathic short statureGrowth Disorders +[6] 
Approved Indications in ChinaGrowth hormone deficiency
Original Approved Country/TerritoryUnited States
Original Approved Date1995/08/24
Country/TerritoryCzechiaBelgiumBulgaria +[16] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaWithdrawn
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncUniversity Of CalgaryPharmacia +[4] 
Inactive CompaniesOregon Health And Science UniversityHanAll Biopharma Co LtdLudwig Maximilians University Of Munich +[5] 
Active IndicationsGrowth hormone deficiencyCoronavirus Disease 2019 (COVID-19)Idiopathic short stature +[13] 
Inactive IndicationsFailure to ThriveEndocrine System DiseasesPremature Birth +[6] 

Other Information

ATC CodeH01AC01
Related LinksDrugBankKEGG